TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PHVS

Pharvaris BV

Healthcare · Biotechnology

32.00$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Pharvaris BV (PHVS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.3% of the shares are freely tradable; institutional investors hold 85.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 85.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 62.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 70Mio.

Largest Shareholders

Institutions

Institutions PHVS
Name Stake (%) Shares Change (%) Date
General Atlantic Llc 9.33 6,550,757 -18.4 06/30/2026
FMR Inc 8.95 6,284,472 -1.8 03/31/2026
Foresite Capital Management IV, LLC 6.81 4,778,581 +0.0 06/30/2026
venBio Partners LLC 6.61 4,643,430 +0.1 06/30/2026
Viking Global Investors LP 5.20 3,653,310 +0.0 03/31/2026
EQT Fund Management S.à r.l. 4.88 3,424,609 +0.0 06/30/2026
Deerfield Management Co 4.45 3,126,042 +0.0 03/31/2026
Bain Capital Life Sciences Investors, LLC 3.81 2,675,509 -4.5 03/31/2026
Wellington Management Company LLP 3.41 2,392,934 +12.9 06/30/2026
COMMODORE CAPITAL LP 2.73 1,918,970 +1.6 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings PHVS
Person Role Shares Value As of Type
Modig Berndt Chief Executive Officer 778,334 24,906,688 $ Sep 14, 2026 both
Lesage Anne Chief Early Development 130,419 4,173,408 $ Sep 10, 2026 both
Schikan Johannes Gerardus Christiaan Petrus Director 115,167 3,685,344 $ Sep 22, 2026 direct
Nassif David W. CFO / CLO 113,800 3,641,600 $ Sep 21, 2026 direct
Lu Peng President 110,261 3,528,352 $ Sep 22, 2026 direct
Abele Stefan Andreas Chief Technical Ops Officer 39,068 1,250,176 $ Sep 15, 2026 direct
Souverijns Wim Chief Commercial Officer 39,021 1,248,672 $ Sep 15, 2026 direct
Bjork Elisabeth Director 15,167 485,344 $ Sep 17, 2026 direct
Glassman Robert Director 10,500 336,000 $ Sep 17, 2026 direct
Monges Viviane Director 5,500 176,000 $ Sep 23, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 23, 2026 Monges Viviane Director Sell 11,969 33.05 395,524
Sep 23, 2026 Monges Viviane Director Other 11,969 8.05 96,350
Sep 22, 2026 Lu Peng President Other 45,308 2.59 117,348
Sep 22, 2026 Schikan Johannes Gerardus Christiaan Petrus Director Sell 800 36.19 28,952
Sep 22, 2026 Schikan Johannes Gerardus Christiaan Petrus Director Other 800 20.00 16,000
Sep 21, 2026 Nassif David W. CFO / CLO Other 500 0.00 –
Sep 21, 2026 Nassif David W. CFO / CLO Sell 6,000 36.47 218,801
Sep 17, 2026 Lu Peng President Sell 100,000 35.00 3,500,000
Sep 17, 2026 Lu Peng President Other 100,000 2.59 259,000
Sep 17, 2026 Schikan Johannes Gerardus Christiaan Petrus Director Sell 200,000 35.00 7,000,000
Sep 17, 2026 Bjork Elisabeth Director Sell 52,500 37.89 1,989,409
Sep 17, 2026 Bjork Elisabeth Director Other 17,500 18.14 317,450
Sep 17, 2026 Bjork Elisabeth Director Other 35,000 14.39 503,650
Sep 17, 2026 Glassman Robert Director Sell 14,493 38.56 558,812
Sep 17, 2026 Glassman Robert Director Other 14,493 18.14 262,903
Sep 17, 2026 Lesage Anne Chief Early Development Sell 20,000 38.27 765,466
Sep 17, 2026 Modig Berndt Chief Executive Officer Other 300,000 35.00 10,500,000
Sep 15, 2026 Abele Stefan Andreas Chief Technical Ops Officer Sell 1,400 39.24 54,938
Sep 15, 2026 Abele Stefan Andreas Chief Technical Ops Officer Sell 45,000 38.14 1,716,188
Sep 15, 2026 Abele Stefan Andreas Chief Technical Ops Officer Other 45,000 16.40 738,000
Sep 15, 2026 Glassman Robert Director Sell 8,667 38.27 331,716
Sep 15, 2026 Glassman Robert Director Other 8,667 22.31 193,361
Sep 15, 2026 Souverijns Wim Chief Commercial Officer Sell 6,090 38.99 237,449
Sep 14, 2026 Souverijns Wim Chief Commercial Officer Sell 20,000 39.31 786,126
Sep 14, 2026 Souverijns Wim Chief Commercial Officer Other 20,000 17.43 348,600
Sep 14, 2026 Lu Peng President Other 117 38.02 4,448
Sep 14, 2026 Modig Berndt Chief Executive Officer Sell 2,291 39.40 90,276
Sep 11, 2026 Lu Peng President Other 109 37.51 4,089
Sep 11, 2026 Lu Peng President Sell 15,000 40.13 601,947
Sep 11, 2026 Lu Peng President Other 15,000 2.59 38,850
Sep 10, 2026 Lesage Anne Chief Early Development Sell 30,000 38.30 1,149,084
Sep 10, 2026 Lesage Anne Chief Early Development Other 30,000 8.05 241,500
Sep 9, 2026 Glassman Robert Director Sell 8,000 37.55 300,396
Sep 9, 2026 Glassman Robert Director Other 8,000 20.00 160,000
Sep 8, 2026 Lu Peng President Sell 15,000 40.68 610,134
Sep 8, 2026 Lu Peng President Other 15,000 2.59 38,850
Aug 14, 2026 Modig Berndt Chief Executive Officer Sell 2,292 34.77 79,686
Aug 12, 2026 Lu Peng President Other 117 34.42 4,027
Aug 11, 2026 Lu Peng President Other 109 34.84 3,798
Apr 23, 2026 Anne Lesage Insider Sell 100 30.03 3,003
Apr 23, 2026 Johannes Gerardus Chri Schikan Director Sell 100 30.03 3,003
Apr 23, 2026 Peng Lu Insider Sell 100 30.03 3,003
Apr 22, 2026 Anne Lesage Insider Sell 7,500 30.05 225,375
Apr 22, 2026 Anne Lesage Insider Sell 7,000 30.05 210,350
Apr 22, 2026 Johannes Gerardus Chri Schikan Director Sell 7,000 30.05 210,350
Apr 22, 2026 Peng Lu Insider Sell 7,001 30.05 210,380

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?